AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.01453-06v1
51/5/1830    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Linden, M.
Right arrow Articles by Reinert, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Linden, M.
Right arrow Articles by Reinert, R. R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2007, p. 1830-1834, Vol. 51, No. 5
0066-4804/07/$08.00+0     doi:10.1128/AAC.01453-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Clonal Spread of mef-Positive Macrolide-Resistant Streptococcus pneumoniae Isolates Causing Invasive Disease in Adults in Germany{triangledown}

Mark van der Linden, Adnan Al-Lahham,{dagger} Stefan Haupts, and Ralf René Reinert*

Institute of Medical Microbiology, National Reference Center for Streptococci, University Hospital (RWTH), Aachen, Germany

Received 20 November 2006/ Returned for modification 24 December 2006/ Accepted 16 February 2007

Isolates (3,845) obtained from German adults with invasive pneumococcal disease between 1992 and 2004 were investigated. Of these, 430 isolates (11.2%) were erythromycin A nonsusceptible. Macrolide resistance genotypes and multilocus sequence types were determined. Among the isolates, 35.6% were erm(B) positive and 63.5% were mef positive. Over the study period, the frequency of resistance rose significantly from 2.2 to 17.0% (P < 0.001). A serotype 14, sequence type 9 clone was the most widespread.


* Corresponding author. Mailing address: Institute for Medical Microbiology, National Reference Center for Streptococci, University Hospital, Pauwelsstr. 30, Aachen, Germany. Phone: 49 241 8089946. Fax: 49 241 8082483. E-mail: Reinert{at}rwth-aachen.de

{triangledown} Published ahead of print on 26 February 2007.

{dagger} Present address: School of Applied Medical Sciences, German-Jordanian University, Amman, Jordan.


Antimicrobial Agents and Chemotherapy, May 2007, p. 1830-1834, Vol. 51, No. 5
0066-4804/07/$08.00+0     doi:10.1128/AAC.01453-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.